English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

To prevent IPD there are currently three vaccines available – two polysaccharide conjugate vaccines, covering 10 and 13 serotypes (PCV10 and PCV13, respectively) and one polysaccharide vaccine, targeting 23 serotypes (PPV23). In Portugal, PCV13 has been the most widely used pneumococcal vaccine in children since its introduction, in early 2010 (>60% coverage in 2012). In 2015, PCV13 vaccine was included in the national immunization program (NIP) for children. For adults, PCV13 and PPV23 are available since 2012 and 1996, respectively, but with low usage.

open forum infectious diseases

Serotypes and Antimicrobial Resistance of Isolates Causing Invasive Pneumococcal Disease in Adult Patients in Portugal After the 13-Valent Conjugate Vaccine Received an Adult Indication, 2012–2014